Martinez Chanza, Nieves http://orcid.org/0000-0001-8970-911X
Bernard, Brandon
Barthelemy, Philippe
Accarain, Anna http://orcid.org/0000-0003-0558-1134
Paesmans, Marianne
Desmyter, Laurence http://orcid.org/0000-0002-4531-4420
T’Kint de Roodenbeke, Daphne
Gil, Thierry
Sideris, Spyridon
Roumeguere, Thierry http://orcid.org/0000-0002-5377-8137
Hamid, Anis A.
Sweeney, Christopher J.
Article History
Received: 20 January 2021
Revised: 23 April 2021
Accepted: 19 May 2021
First Online: 9 June 2021
Compliance with ethical standards
:
: NMC reports support for research travel from Pfizer, Janssen and Ipsen, and consulting fees for BMS, Pfizer, Sanofi, and Bayer. TR reported supports for reseach travel from Janssen and consulting fees for BMS, Pfizer, MSD, and Astellas. Disclosure statement for CJS, MBBS: Consulting or Advisory Role: Sanofi, Janssen, Astellas Pharma, Bayer, Genentech, AstraZeneca, Pfizer, Lilly, Research Funding: Janssen Biotech (Inst), Astellas Pharma (Inst), Sanofi (Inst), Bayer (Inst), Dendreon (Inst); Patents, Royalties, Other Intellectual Property: Pathenolide (Indiana University): dimethylaminoparthenolide (Leuchemix); Exelixis: Abiraterone plus cabozantinib combination. Stock or Other Ownership: Leuchemix. Other authors do not declare any conflict of interest.